insights_auto
Why is GH up 5.30%?
Dive Deeperchevron_right
GH:NASDAQ
Guardant Health Inc
$187.22
arrow_upward
+5.30%(+9.42) 1D
$189.39
arrow_upward
+1.16% (+2.17)bedtimeAfter hours
Closed: Oct 5, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GH...
Open
$177.45
High
$187.69
Low
$176.37
Mkt. cap
25.12B
Avg. vol.
1.82M
Volume
1.74M
52-wk high
$187.69
52-wk low
$61.00
EPS
-$3.50
Beta
1.58
Shares outstanding
134.20M
No. of employees
2K
Open
$177.45
High
$187.69
Low
$176.37
Mkt. cap
25.12B
Avg. vol.
1.82M
Volume
1.74M
52-wk high
$187.69
52-wk low
$61.00
EPS
-$3.50
Beta
1.58
Shares outstanding
134.20M
No. of employees
2K
News stories
From web sources and news partners
Investing.com Canada
·
6 hours ago
Guardant Health stock hits all-time high at 183.69 USD By Investing.com
Stock Titan
·
7 hours ago
A blood test found signs of melanoma returning a median 70.5 days before clinical detection
Profile
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
About Guardant Health Inc
CEOHelmy Eltoukhy | AmirAli Talasaz
Employees2.5K
Founded2012
HeadquartersPalo Alto, California, United States
SectorHealth care provider
Websiteguardanthealth.com